Tikun Olam-Cannbit Pharmaceuticals Ltd (TKUN.TA)
ILA 38.4
(12.61%)
ILA 38.4
(12.61%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -32.98 Million ILS | -1211.69% |
| 2022 | 4.83 Million ILS | 122.62% |
| 2021 | -13.04 Million ILS | 30.18% |
| 2020 | -19.89 Million ILS | -74.18% |
| 2019 | -9.94 Million ILS | 48.97% |
| 2018 | - ILS | -4813.24% |
| 2017 | - ILS | 52.9% |
| 2016 | - ILS | 68.07% |
| 2015 | - ILS | 30.53% |
| 2014 | -4.04 Million ILS | 69.66% |
| 2013 | - ILS | 33.84% |
| 2012 | -20.16 Million ILS | -189.95% |
| 2011 | 22.42 Million ILS | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -1.76 Million ILS | 80.42% |
| 2024 Q2 | -1.76 Million ILS | 0.0% |
| 2023 Q4 | -9.03 Million ILS | 0.0% |
| 2023 FY | - ILS | -1211.69% |
| 2023 Q2 | -9.88 Million ILA | 0.0% |
| 2023 Q3 | -9.03 Million ILS | 8.61% |
| 2023 Q1 | -9.88 Million ILS | -123.14% |
| 2022 Q2 | 245.5 Thousand ILA | 0.0% |
| 2022 Q4 | -4.42 Million ILA | 0.0% |
| 2022 FY | - ILS | 122.62% |
| 2022 Q1 | 245.5 Thousand ILS | 102.37% |
| 2022 Q3 | -4.42 Million ILS | -1904.28% |
| 2021 Q2 | -2.67 Million ILS | 0.0% |
| 2021 Q1 | -2.67 Million ILS | 73.19% |
| 2021 FY | - ILS | 30.18% |
| 2021 Q3 | -10.2 Million ILS | -281.95% |
| 2021 Q4 | -10.34 Million ILS | -1.44% |
| 2020 Q4 | -9.96 Million ILS | 0.0% |
| 2020 FY | - ILS | -74.18% |
| 2020 Q2 | 19 Thousand ILS | 0.0% |
| 2020 Q3 | -9.96 Million ILS | -52544.74% |
| 2020 Q1 | 19 Thousand ILS | 100.38% |
| 2019 Q1 | -480 Thousand ILS | 95.2% |
| 2019 Q2 | -480 Thousand ILS | 0.0% |
| 2019 FY | - ILS | 48.97% |
| 2019 Q3 | -1.19 Million ILS | -147.92% |
| 2019 Q4 | -5.02 Million ILS | -321.97% |
| 2018 Q2 | -26 Thousand ILS | 0.0% |
| 2018 Q4 | -9.99 Million ILS | 0.0% |
| 2018 Q3 | -9.99 Million ILS | -38357.69% |
| 2018 Q1 | -26 Thousand ILS | 0.0% |
| 2018 FY | - ILS | -4813.24% |
| 2017 FY | - ILS | 52.9% |
| 2016 Q4 | -26 Thousand ILS | 95.83% |
| 2016 Q3 | -623 Thousand ILS | -2325.0% |
| 2016 FY | - ILS | 68.07% |
| 2016 Q2 | 28 Thousand ILS | 110.11% |
| 2016 Q1 | -277 Thousand ILS | 65.07% |
| 2015 Q1 | -2.17 Million ILS | -38.07% |
| 2015 Q4 | -793 Thousand ILS | -2.19% |
| 2015 Q3 | -776 Thousand ILS | -184.26% |
| 2015 Q2 | 921 Thousand ILS | 142.33% |
| 2015 FY | - ILS | 30.53% |
| 2014 Q1 | -486 Thousand ILS | 51.83% |
| 2014 Q2 | -1.52 Million ILS | -214.61% |
| 2014 FY | - ILS | 69.66% |
| 2014 Q3 | -457 Thousand ILS | 70.11% |
| 2014 Q4 | -1.57 Million ILS | -244.86% |
| 2013 Q2 | -22 Thousand ILS | 99.81% |
| 2013 FY | - ILS | 33.84% |
| 2013 Q4 | -1 Million ILS | -486.63% |
| 2013 Q1 | -11.73 Million ILS | 0.0% |
| 2013 Q3 | -172 Thousand ILS | -681.82% |
| 2012 FY | - ILS | -189.95% |
| 2011 FY | - ILS | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Cannabotech LTD | -14.81 Million ILA | -122.687% |